Literature DB >> 21719337

Disseminated cutaneous sporotrichosis in an immunocompetent individual.

Felix Boon-Bin Yap1.   

Abstract

Sporotrichosis is a subacute or chronic fungal infection caused by the ubiquitous fungus Sporothrix schenckii. Disseminated cutaneous sporotrichosis is an uncommon entity and is usually present in the immunosuppressed. Here, a case of disseminated cutaneous sporotrichosis in an immunocompetent patient is reported. This 70-year-old healthy woman presented with multiple painful ulcerated nodules on her face and upper and lower extremities of 6-month duration, associated with low-grade fever, night sweats, loss of appetite, and loss of weight. Histopathological examination of the skin biopsy revealed epidermal hyperplasia and granulomatous inflammation in the dermis, with budding yeast. Fungal culture identified S. schenckii. She had total resolution of the lesions after 2 weeks of intravenous amphotericin B and 8 months of oral itraconazole. All investigations for underlying immunosuppression and internal organ involvement were negative. This case reiterates that disseminated cutaneous sporotrichosis, although common in the immunosuppressed, can also be seen in immunocompetent patients.
Copyright © 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21719337     DOI: 10.1016/j.ijid.2011.05.005

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  10 in total

1.  Molecular identification of Sporothrix clinical isolates in China.

Authors:  Ting-ting Liu; Ke Zhang; Xun Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2014-01       Impact factor: 3.066

2.  In Vitro and In Vivo Efficacy of Amphotericin B Combined with Posaconazole against Experimental Disseminated Sporotrichosis.

Authors:  Débora Nunes Mario; Josep Guarro; Janio Morais Santurio; Sydney Hartz Alves; Javier Capilla
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

3.  Cutaneous disseminated sporotrichosis in immunocompetent patient: Case report and literature review.

Authors:  Flávio Queiroz-Telles; Regielly Caroline Cognialli; Gabriel Lucca Salvador; Gabriela Araujo Moreira; Patricia Fernanda Herkert; Ferry Hagen
Journal:  Med Mycol Case Rep       Date:  2022-05-08

4.  Construction and analysis of the cDNA subtraction library of yeast and mycelial phases of Sporothrix globosa isolated in China: identification of differentially expressed genes.

Authors:  Qing-bi Hu; Yu He; Xun Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2015-12       Impact factor: 3.066

5.  Genome Sequence of the Pathogenic Fungus Sporothrix schenckii (ATCC 58251).

Authors:  Christina A Cuomo; Nuri Rodriguez-Del Valle; Lizaida Perez-Sanchez; Amr Abouelleil; Jonathan Goldberg; Sarah Young; Qiandong Zeng; Bruce W Birren
Journal:  Genome Announc       Date:  2014-05-22

6.  Recombinant Phage Elicits Protective Immune Response against Systemic S. globosa Infection in Mouse Model.

Authors:  Feng Chen; Rihua Jiang; Yicun Wang; Mingji Zhu; Xu Zhang; Shuai Dong; Hongxi Shi; Li Wang
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

7.  Disseminated sporotrichosis in a person with human immunodeficiency virus disease.

Authors:  Vhudzani Tshisevhe; Lebogang Skosana; Kagiso Motse; Tinashe Maphosa; Barend Mitton
Journal:  Access Microbiol       Date:  2021-09-21

8.  Therapeutic monoclonal antibody for sporotrichosis.

Authors:  Sandro R Almeida
Journal:  Front Microbiol       Date:  2012-11-28       Impact factor: 5.640

Review 9.  Cutaneous Disseminated and Extracutaneous Sporotrichosis: Current Status of a Complex Disease.

Authors:  Alexandro Bonifaz; Andrés Tirado-Sánchez
Journal:  J Fungi (Basel)       Date:  2017-02-10

10.  Disseminated Cutaneous and Osteoarticular Sporotrichosis Mimicking Pyoderma Gangrenosum.

Authors:  Lina Saeed; Robert J Weber; Sarah B Puryear; Eman Bahrani; Michael J Peluso; Jennifer M Babik; Anna Haemel; Sarah J Coates
Journal:  Open Forum Infect Dis       Date:  2019-09-09       Impact factor: 3.835

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.